Stachydrine prevents LPS‐induced bone loss by inhibiting osteoclastogenesis via NF‐κB and Akt signalling

Osteoclast overactivation‐induced imbalance in bone remodelling leads to pathological bone destruction, which is a characteristic of many osteolytic diseases such as rheumatoid arthritis, osteoporosis, periprosthetic osteolysis and periodontitis. Natural compounds that suppress osteoclast formation...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jiahong, Zhou, Chenhe, Zhang, Wenkan, Wang, Wei, He, Bin, Hu, Bin, Jiang, Guangyao, Wang, Yangxin, Hong, Jianqiao, Li, Sihao, He, Jiamin, Yan, Shigui, Yan, Weiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787569/
https://www.ncbi.nlm.nih.gov/pubmed/31328430
http://dx.doi.org/10.1111/jcmm.14551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787569/
https://www.ncbi.nlm.nih.gov/pubmed/31328430
http://dx.doi.org/10.1111/jcmm.14551

Ejemplares similares